In a major step toward more reliable AI-assisted molecular design, researchers from National Taiwan University have ...

What to do: Consult a health care professional if you have used an unauthorized injectable peptide drug and have health concerns. Do not buy or use unauthorized drugs. Only buy prescription drugs from ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

The injectable GLP-1 drugs are peptides — small fragments of proteins. (GLP stands for glucagon-like peptide.) Peptides are digested by the stomach. So, in order to make an oral GLP-1 ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed.

Cyprumed may receive up to $493 million in milestone payments from Merck for peptide drug delivery tech. Merck’s pipeline includes Phase 3 PCSK9 inhibitor and GLP-1/glucagon receptor agonist.

Exscientia said this is a milestone for drug discovery, as the entire project took 12 months instead of the usual five years. Exscientia claims world first as AI-created drug enters clinic ...

Currently available GLP-1 drugs are engineered peptides that must be administered as injections. Novo Nordisk already sells an oral GLP-1 type 2 diabetes drug, Rybelsus. This pill contains ...

Cyprumed GmbH, and MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA), announced that the companies have signed a Non-Exclusive License and Option Agreement to develop oral formulations of MSD’s ...

Zynext Ventures USA LLC today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage ...

AUSTIN, Texas, April 15, 2025 (GLOBE NEWSWIRE) -- AutoScheduler.AI, an innovative Warehouse Orchestration Platform and WMS accelerator, announces that CEO Keith Moore and Axel Arias, Senior ...